CDC issues Request for Proposal to develop new serology test for Herpes Simplex Virus

The Centers for Disease Control and Prevention (CDC), the Office of Science (OS) in late December 2022 issued a Broad Agency Announcement (BAA) for the competitive selection of research proposals, including a Request for Proposal (RFP) for a new serologic test for herpes simplex virus (HSV). Therefore, the goal of the RFP is to develop,Continue reading “CDC issues Request for Proposal to develop new serology test for Herpes Simplex Virus”

New Clinical Study for Broad spectrum anti-viral to treat HPV, Mpox, and possibly herpes

Hyundai Biosciences have applied for a clinical study in Korea to test the efficacy of CP-COVO3, a new candidate treatment for viral infections, on HPV. This antiviral agent, developed in Korea, has an innovative ‘viral removal’ mechanism applicable to all viruses, unlike existing antiviral agents that target only specific viruses. It is expected to openContinue reading “New Clinical Study for Broad spectrum anti-viral to treat HPV, Mpox, and possibly herpes”

BioNTech New Clinical Trial for Herpes Vaccine begins

December 21 2022, BioNTech announced they had dosed the first clinical trial participant. This is the first-in-human study aims to evaluate the safety and immunogenicity of prophylactic herpes virus vaccine candidate BNT163. Company statement; “We aim to help address diseases with a high unmet medical need and of global health relevance, and we are combiningContinue reading “BioNTech New Clinical Trial for Herpes Vaccine begins”

Meet the Experts

A series of talks with experts in herpes simplex virus research, commercial partners in vaccine or treatment development, sexual health, and more. Learn more about clinical trials, the latest science, advances in technology, and the role of patient advocacy. UPenn/BioNTech Clinical Trials: Latest updates and Q&A with Dr Harvey Friedman January 11th, 6pm EST Dr.Continue reading “Meet the Experts”

Testing for Herpes: Step-by-Step Guide

How to get tested for Herpes Testing for herpes is complicated and can be confusing in America. Currently available, FDA-approved IgG antibody tests sometimes present with false positive results where the test says you are infected with HSV and you are not. Tests can also have false negative results. Most often, false positive results areContinue reading “Testing for Herpes: Step-by-Step Guide”

We lost our baby daughter to neonatal herpes

We lost our baby to neonatal herpes, and her life mattered. Our daughter would be turning a year old this coming September 2022. Instead of celebrating her birth, though, we will be gathering to memorialize her 27 days of life. Our daughter died a horrible death due to acquiring HSV-2 in the birth canal, alsoContinue reading “We lost our baby daughter to neonatal herpes”

Important Win for Herpes Advocacy: FY 2023 Congress Budget Update

Herpes Cure Advocacy celebrates and thanks the US House of Representatives for their prioritization of federal action for Herpes Simplex Virus cure, treatment and prevention in the FY 2023 House budget report. In the house budget report for FY 2023, published on June 29, there is report language that directs NIH to assemble a multi-councilContinue reading “Important Win for Herpes Advocacy: FY 2023 Congress Budget Update”

Possible herpes keratitis cure takes another step: BDGene of China applies for Orphan Drug Designation at the FDA

Chinese company BDGene from Shanghai continues to lead in the global race for a herpes keratitis cure. The highly anticipated treatment, BD111 has reached a big milestone as it applied for Orphan Drug designation from the US FDA. Previously, BD111 has received international attention for its progress with a gene editing cure for herpes keratitis.Continue reading “Possible herpes keratitis cure takes another step: BDGene of China applies for Orphan Drug Designation at the FDA”

New Clinical Trial for Herpes Vaccine from Biontech + UPenn

The BioNTech team and UPenn have previously partnered on pre-clinical study of an mRNA-based vaccine candidate to prevent genital herpes. This work is led by lead investigator Dr. Harvey Friedman and team at the University of Pennsylvania. A new clinical trial A Clinical Trial in Healthy Volunteers to Study the Safety, Tolerability, and Immune ResponsesContinue reading “New Clinical Trial for Herpes Vaccine from Biontech + UPenn”

New Clinical Trial for Herpes Simplex Virus

GlaxoSmithKline Pipeline Update GSK has officially updated its clinical research pipeline to include a vaccine for HSV-2! Their therapeutic vaccine for HSV-2 isn’t mRNA (or what they called SAM technology) but an adjuvanted therapeutic vaccine. The trial (currently recruiting) is a Phase 1/2 combined trial that ends in 2024. GSK will test 9 different formulationsContinue reading “New Clinical Trial for Herpes Simplex Virus”